Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.

Mar R, Pajukanta P, Allayee H, Groenendijk M, Dallinga-Thie G, Krauss RM, Sinsheimer JS, Cantor RM, de Bruin TW, Lusis AJ.

Circ Res. 2004 Apr 16;94(7):993-9. Epub 2004 Mar 4.

2.

Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.

Eichenbaum-Voline S, Olivier M, Jones EL, Naoumova RP, Jones B, Gau B, Patel HN, Seed M, Betteridge DJ, Galton DJ, Rubin EM, Scott J, Shoulders CC, Pennacchio LA.

Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):167-74. Epub 2003 Oct 9.

3.

Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.

Dallinga-Thie GM, Bu XD, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TW.

J Lipid Res. 1996 Jan;37(1):136-47.

4.

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Yin RX, Li YY, Lai CQ.

Lipids Health Dis. 2011 Aug 19;10:140. doi: 10.1186/1476-511X-10-140.

5.

Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.

Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B.

Atherosclerosis. 2010 Feb;208(2):427-32. doi: 10.1016/j.atherosclerosis.2009.08.013. Epub 2009 Aug 15.

PMID:
19732897
6.

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

van der Vleuten GM, Isaacs A, Zeng WW, ter Avest E, Talmud PJ, Dallinga-Thie GM, van Duijn CM, Stalenhoef AF, de Graaf J.

Biochim Biophys Acta. 2007 Jan;1772(1):81-8. Epub 2006 Oct 26.

7.

Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.

Liu Y, Ordovas JM, Gao G, Province M, Straka RJ, Tsai MY, Lai CQ, Zhang K, Borecki I, Hixson JE, Allison DB, Arnett DK.

Pharmacogenet Genomics. 2009 Feb;19(2):161-9. doi: 10.1097/FPC.0b013e32831e030e.

8.

Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.

Wu Y, Yu Y, Zhao T, Wang S, Fu Y, Qi Y, Yang G, Yao W, Su Y, Ma Y, Shi J, Jiang J, Kou C.

PLoS One. 2016 Jan 29;11(1):e0147946. doi: 10.1371/journal.pone.0147946. eCollection 2016.

9.

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter JI, Cantor RM, Bu X, Lusis AJ, de Bruin TW.

J Clin Invest. 1997 Mar 1;99(5):953-61.

10.

Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.

Qi L, Liu S, Rifai N, Hunter D, Hu FB.

Atherosclerosis. 2007 May;192(1):204-10. Epub 2006 Jun 16.

PMID:
16781717
11.

[A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].

Liu HK, Zhang SZ, Su ZG, Ma YX, Wang CT.

Yi Chuan. 2004 Nov;26(6):953-6. Review. Chinese.

PMID:
15640132
12.

Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.

Groenendijk M, Cantor RM, Blom NH, Rotter JI, de Bruin TW, Dallinga-Thie GM.

J Lipid Res. 1999 Jun;40(6):1036-44.

13.

Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome.

Ding Y, Zhu MA, Wang ZX, Zhu J, Feng JB, Li DS.

J Biomed Biotechnol. 2012;2012:509420. doi: 10.1155/2012/509420. Epub 2012 May 23.

14.

Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.

Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J, Parnell LD, Garcia-Rios A, Ordovas JM, Lopez-Miranda J.

J Lipid Res. 2010 Jan;51(1):63-73. doi: 10.1194/jlr.M800527-JLR200.

15.

Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population.

Chien KL, Chen MF, Hsu HC, Su TC, Chang WT, Lee CM, Lee YT.

Clin Chim Acta. 2008 Feb;388(1-2):78-83. Epub 2007 Oct 11.

PMID:
17964293
16.

SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.

Wright WT, Young IS, Nicholls DP, Patterson C, Lyttle K, Graham CA.

Atherosclerosis. 2006 Apr;185(2):353-60. Epub 2005 Aug 25.

PMID:
16125709
17.

Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

Olivier M, Wang X, Cole R, Gau B, Kim J, Rubin EM, Pennacchio LA.

Genomics. 2004 May;83(5):912-23.

18.

Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.

Allayee H, Aouizerat BE, Cantor RM, Dallinga-Thie GM, Krauss RM, Lanning CD, Rotter JI, Lusis AJ, de Bruin TW.

Am J Hum Genet. 1998 Aug;63(2):577-85.

19.

The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk.

Lai CQ, Parnell LD, Ordovas JM.

Curr Opin Lipidol. 2005 Apr;16(2):153-66. Review.

PMID:
15767855
20.

Supplemental Content

Support Center